Vertex Pharmaceuticals (NQ:VRTX)

As 2025 draws to a close, a powerful undercurrent of technological innovation, extending far beyond the pervasive influence of artificial intelligence, is demonstrably reshaping the global stock...

Beyond AI: How Non-AI Tech Innovations are Fueling a New Era of Stock Market Growth

December 11, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

1 Large-Cap Stock to Consider Right Now and 2 Facing Challenges

December 08, 2025

The stock has fallen from a peak back in April.

Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? ↗

December 06, 2025

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions

December 06, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

1 Reason I'll Never Sell Vertex Pharmaceuticals Stock ↗

December 04, 2025

The stock has climbed in the double-digits in recent years.

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Topics Intellectual Property

Which S&P500 stocks are moving on Wednesday? ↗

December 03, 2025

Via Chartmill

Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today

December 03, 2025

Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 6.2% in the afternoon session after Morgan Stanley upgraded its rating on the stock to "Overweight" from "Equal-Weight" and...

Stay updated with the movements of the S&P500 index in the middle of the day on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.

Topics Artificial Intelligence Economy

What's going on in today's session: S&P500 movers ↗

December 03, 2025

Via Chartmill

2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗

December 03, 2025

Both can help drive excellent returns for patient, disciplined investors.

These stocks deserve a spot on investors' shopping lists this holiday season.

Topics Artificial Intelligence

3 Top Stocks to Buy in December ↗

December 01, 2025

Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% ↗

November 30, 2025

This company's first product has started to generate revenue.

Vertex (VRTX) Q3 2025 Earnings Call Transcript

Topics ETFs

Vertex (VRTX) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Prediction: Vertex will be much larger by the end of the decade.

Topics Earnings

Where Will Vertex Pharmaceuticals Be in 5 Years ↗

November 27, 2025

If you're investing for the next 30 years, don't overlook these top stocks.

2 Healthcare Stocks For Beginner Investors With a 30-Year Time Horizon ↗

November 23, 2025

Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 2.7% in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut.

Topics Intellectual Property

Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why

November 21, 2025

Inflation should have a minimal impact on these companies' financial results. And they also boast excellent growth prospects.

Topics Artificial Intelligence Economy Supply Chain

2 Inflation-Proof Growth Stocks That Could Outperform the Market ↗

November 20, 2025

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Presents a Compelling Case for Value Investors ↗

Topics Economy Intellectual Property

November 20, 2025

Vertex Pharmaceuticals (VRTX) presents a strong value investment case with a low P/E ratio, robust profitability, a healthy debt-free balance sheet, and accelerating earnings growth.

Via Chartmill

Agios Pharmaceuticals Plunges Over 50% as Sickle Cell Drug Delivers Mixed Phase 3 Results

November 19, 2025

Boston, MA – November 19, 2025 – Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) experienced a dramatic and immediate market backlash, with its stock plummeting over 51.00% following the announcement of...

Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today ↗

Vertex to Participate in the Citi’s 2025 Global Healthcare Conference on December 3

November 19, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

November 19, 2025

Via Benzinga

1 Cash-Heavy Stock with Solid Fundamentals and 2 We Ignore

November 19, 2025

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...

These stocks both have advanced in the double-digits in recent months.

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

November 19, 2025

It's a good idea to go against the current market sentiment on this one.

Is Vertex Pharmaceuticals Inc Gaining or Losing Market Support? ↗

November 17, 2025

Via Benzinga

1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November ↗

November 17, 2025

The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market

November 14, 2025

The global financial markets are in the midst of a profound transformation, driven by an accelerating wave of technological advancements. From the intricate algorithms of Artificial Intelligence to the...

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Topics Artificial Intelligence ETFs Economy

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 14, 2025

Via Benzinga

1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off

November 12, 2025

Vertex Pharmaceuticals offers strong growth, solid profits, and a healthy balance sheet, all at a reasonable valuation compared to its biotech peers.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Top Affordable Growth Stock ↗

November 12, 2025

Via Chartmill

Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds

November 10, 2025

New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers...